Venture Capital Archives - Page 37 of 99

MassBio Pushes Back Against ‘Most Favored Nation’ Drug Pricing Policy Following Executive Order

May 14, 2025

Large Study Confirms Safety and Life-Saving Benefits of Contrast-Enhanced Ultrasound

May 14, 2025

Stylus Medicine Launches With $85M to Advance In Vivo Genetic Medicines and Next-Generation CAR-T Therapies

May 13, 2025

THIS WEEK'S STORIES

Zynex Submits FDA Application for Breakthrough Laser Pulse Oximeter

May 12, 2025

AstraZeneca’s IMFINZI Shows Significant Benefit in Early Bladder Cancer, Phase III Trial Finds

May 9, 2025

Sensory Cloud Completes Enrollment for Phase 2a Trial Targeting Refractory Chronic Cough

May 14, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Venture Capital

VILAS Ventures Backs $13.5M Series A3 Round for CND Life Sciences to Accelerate Neurodegenerative Diagnostics

Denali Growth Partners Closes $400 Million Second Fund to Back High-Growth, Capital-Efficient Companies

Jaanuu Acquired by VentureOn Management in Strategic Asset Sale

HAYA Therapeutics Secures $65 Million Series A to Advance RNA-Guided Therapies for Chronic and Age-Related Diseases

TSOLife Raises $43 Million Series B to Advance AI-Driven Innovation in Senior Living Communities

Most Read

Mirvie Launches Encompass™, a First-of-Its-Kind Predictive Test for Preeclampsia, Marking a Shift Toward Personalized Prenatal Care

Michael Dowling to Step Down as Northwell Health CEO After 23 Years, John D’Angelo Named Successor

Median Technologies Files FDA Application for AI-Powered Lung Cancer Screening Software

Eight Sleep Launches Pod 5, the First AI-Powered Sleep System with Temperature Control, Elevation, Sound, and Real-Time Health Monitoring

EDITOR PICKS

MassBio Pushes Back Against ‘Most Favored Nation’ Drug Pricing Policy Following Executive Order

Large Study Confirms Safety and Life-Saving Benefits of Contrast-Enhanced Ultrasound

Stylus Medicine Launches With $85M to Advance In Vivo Genetic Medicines and Next-Generation CAR-T Therapies

THIS WEEK'S STORIES

Zynex Submits FDA Application for Breakthrough Laser Pulse Oximeter

AstraZeneca’s IMFINZI Shows Significant Benefit in Early Bladder Cancer, Phase III Trial Finds

Sensory Cloud Completes Enrollment for Phase 2a Trial Targeting Refractory Chronic Cough

POPULAR CATEGORY

ABOUT US

FOLLOW US